Literature DB >> 11009179

Neuropsychologic assessment of patients for movement disorder surgery.

J A Saint-Cyr1, L L Trépanier.   

Abstract

The neuropsychologic evaluation of patients under consideration for movement disorder surgery is recognized as being an essential component of the preoperative process. Patients with early-stage concomitant dementia must be identified and the relative risk of postoperative cognitive decline evaluated. Knowledge of the patterns of an individual's strengths and weaknesses might also be a factor in deciding on a neurosurgical procedure. Although the advent of pallidal deep brain stimulation (DBS) has possibly resulted in reduced risk of induced cognitive impairment, even this procedure has been associated with negative sequelae. DBS within the subthalamic nucleus is becoming the method of choice and this may lead to cognitive and behavioral compromise, especially in the elderly patient. The team considering the establishment of neurosurgical treatment is often at a loss to decide how much neuropsychologic testing is required to determine relative risks of cognitive or behavioral morbidity as a consequence of the procedure. A brief summary of expected outcome and of pertinent family process and psychodynamic issues are addressed. This article is intended to serve as a guide to permit clinicians to choose the appropriate length and depth of neuropsychologic assessment, but also to highlight the confounding factors often present in these patients.

Entities:  

Mesh:

Year:  2000        PMID: 11009179     DOI: 10.1002/1531-8257(200009)15:5<771::aid-mds1003>3.0.co;2-y

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.

Authors:  D De Gaspari; C Siri; A Landi; R Cilia; A Bonetti; F Natuzzi; L Morgante; C B Mariani; E Sganzerla; G Pezzoli; A Antonini
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 2.  Neuropsychiatric aspects of Parkinson's disease: recent advances.

Authors:  Laura Marsh; Ariel Berk
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

3.  Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD--a comparison of neuropsychological effects.

Authors:  Harriet M M Smeding; Rianne A J Esselink; Ben Schmand; Marthe Koning-Haanstra; Ilse Nijhuis; Elze M Wijnalda; Johannes D Speelman
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

4.  Parkinson's Disease: Surgical Options.

Authors:  Helen Bronte-Stewart
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

Review 5.  Influence of deep brain stimulation of the subthalamic nucleus on cognitive function in patients with Parkinson's disease.

Authors:  Bin Wu; Lu Han; Bo-Min Sun; Xiao-Wu Hu; Xiao-Ping Wang
Journal:  Neurosci Bull       Date:  2013-12-12       Impact factor: 5.203

Review 6.  Neuropathic pain and deep brain stimulation.

Authors:  Erlick A C Pereira; Tipu Z Aziz
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

7.  Surgical management of Parkinson's disease: update and review.

Authors:  Y Chao; L Gang; Z L Na; W Y Ming; W S Zhong; W S Mian
Journal:  Interv Neuroradiol       Date:  2008-02-01       Impact factor: 1.610

Review 8.  Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a critical review.

Authors:  Steven Paul Woods; Julie A Fields; Alexander I Tröster
Journal:  Neuropsychol Rev       Date:  2002-06       Impact factor: 7.444

Review 9.  Effect of subthalamic stimulation on mood state in Parkinson's disease: evaluation of previous facts and problems.

Authors:  Shinichiro Takeshita; Kaoru Kurisu; Liat Trop; Kazunori Arita; Tomohide Akimitsu; Nicolaas Paul L G Verhoeff
Journal:  Neurosurg Rev       Date:  2005-04-13       Impact factor: 3.042

10.  Dual channel deep brain stimulation system (Kinetra) for Parkinson's disease and essential tremor: a prospective multicentre open label clinical study.

Authors:  J Vesper; S Chabardes; V Fraix; N Sunde; K Østergaard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.